Diagnostic Tools for Coronavirus Disease (COVID-19) : Comparing CT and RT-PCR Viral Nucleic Acid Testing

OBJECTIVE. Multiple studies suggest CT should be a primary diagnostic tool for coronavirus disease (COVID-19) because they reported sensitivities with CT far superior to that of reverse transcriptase polymerase chain reaction (RT-PCR) testing. This review aimed to assess these reports and found chest CT to have a clinical utility that is limited, particularly for patients who show no symptoms and patients who are screened early in disease progression. CONCLUSION. CT has limited sensitivity for COVID-19 and a lower specificity than RT-PCR testing, and it carries a risk of exposing providers to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Chest CT should be considered a supplemental diagnostic tool, particularly for patients who show symptoms.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:215

Enthalten in:

AJR. American journal of roentgenology - 215(2020), 4 vom: 28. Okt., Seite 834-838

Sprache:

Englisch

Beteiligte Personen:

Waller, Joseph V [VerfasserIn]
Kaur, Parveer [VerfasserIn]
Tucker, Amy [VerfasserIn]
Lin, Keldon K [VerfasserIn]
Diaz, Michael J [VerfasserIn]
Henry, Travis S [VerfasserIn]
Hope, Michael [VerfasserIn]

Links:

Volltext

Themen:

COVID-19
Chest CT
Coronavirus disease
Journal Article
RT-PCR
Review
SARS-CoV-2
Sensitivity
Severe acute respiratory syndrome coronavirus 2
Specificity

Anmerkungen:

Date Completed 01.10.2020

Date Revised 18.12.2020

published: Print-Electronic

Citation Status MEDLINE

doi:

10.2214/AJR.20.23418

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM309954878